Literature DB >> 18178811

The effect of deleting p110delta on the phenotype and function of PTEN-deficient B cells.

Michelle L Janas1, Daniel Hodson, Zania Stamataki, Sue Hill, Katie Welch, Laure Gambardella, Lloyd C Trotman, Pier Paolo Pandolfi, Elena Vigorito, Martin Turner.   

Abstract

Control of the intracellular levels of phosphatidylinositol-(3, 4, 5)-trisphosphate by PI3K and phosphatase and tensin homolog (PTEN) is essential for B cell development and differentiation. Deletion of the PI3K catalytic subunit p110delta leads to a severe reduction in B1 and marginal zone (MZ) B cells, whereas deletion of PTEN results in their expansion. We have examined the relationship between these two molecules by generating mice with a B cell-specific deletion of PTEN (PTENB) and a concurrent germline deletion of p110delta. The expanded B1 cell population of PTENB mice was reduced to normal levels in PTENB/p110delta mutant mice, indicating a critical role for the p110delta isoform in the expansion of B1 cells. However, numbers of MZ B cells in the PTENB/p110delta mutants was intermediate between wild-type and PTENB-deficient mice, suggesting an additional role for other PI3K catalytic isoforms in MZ differentiation. Furthermore, the defective class switch recombination in PTENB B cells was only partially reversed in PTENB/p110delta double mutant B cells. These results demonstrate an epistatic relationship between p110delta and PTEN. In addition, they also suggest that additional PI3K catalytic subunits contribute to B cell development and function.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18178811     DOI: 10.4049/jimmunol.180.2.739

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  20 in total

Review 1.  The emerging mechanisms of isoform-specific PI3K signalling.

Authors:  Bart Vanhaesebroeck; Julie Guillermet-Guibert; Mariona Graupera; Benoit Bilanges
Journal:  Nat Rev Mol Cell Biol       Date:  2010-04-09       Impact factor: 94.444

Review 2.  PI3K signalling in B- and T-lymphocytes: new developments and therapeutic advances.

Authors:  Lomon So; David A Fruman
Journal:  Biochem J       Date:  2012-03-15       Impact factor: 3.857

3.  The viral latency-associated nuclear antigen augments the B-cell response to antigen in vivo.

Authors:  Sang-Hoon Sin; Farnaz D Fakhari; Dirk P Dittmer
Journal:  J Virol       Date:  2010-08-04       Impact factor: 5.103

Review 4.  PI3Ks in lymphocyte signaling and development.

Authors:  Klaus Okkenhaug; David A Fruman
Journal:  Curr Top Microbiol Immunol       Date:  2010       Impact factor: 4.291

5.  The PI3K isoforms p110alpha and p110delta are essential for pre-B cell receptor signaling and B cell development.

Authors:  Faruk Ramadani; Daniel J Bolland; Fabien Garcon; Juliet L Emery; Bart Vanhaesebroeck; Anne E Corcoran; Klaus Okkenhaug
Journal:  Sci Signal       Date:  2010-08-10       Impact factor: 8.192

6.  Imbalanced PTEN and PI3K Signaling Impairs Class Switch Recombination.

Authors:  Zhangguo Chen; Andrew Getahun; Xiaomi Chen; Yonatan Dollin; John C Cambier; Jing H Wang
Journal:  J Immunol       Date:  2015-10-23       Impact factor: 5.422

Review 7.  S1PR2 links germinal center confinement and growth regulation.

Authors:  Jesse A Green; Jason G Cyster
Journal:  Immunol Rev       Date:  2012-05       Impact factor: 12.988

8.  Cowden's syndrome with immunodeficiency.

Authors:  Michael J Browning; Anita Chandra; Valentina Carbonaro; Klaus Okkenhaug; Julian Barwell
Journal:  J Med Genet       Date:  2015-08-05       Impact factor: 6.318

Review 9.  Signaling by the phosphoinositide 3-kinase family in immune cells.

Authors:  Klaus Okkenhaug
Journal:  Annu Rev Immunol       Date:  2013-01-16       Impact factor: 28.527

Review 10.  PI3Kδ and primary immunodeficiencies.

Authors:  Carrie L Lucas; Anita Chandra; Sergey Nejentsev; Alison M Condliffe; Klaus Okkenhaug
Journal:  Nat Rev Immunol       Date:  2016-09-12       Impact factor: 53.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.